Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 324B (ZNF324B) is a member of the large C2H2-type zinc finger protein family, which functions as a DNA-binding transcription factor and is involved in the regulation of gene expression. ZNF324B contains multiple zinc finger domains, including a KRAB (Krüppel-associated box) domain, which are characteristic of proteins capable of mediating sequence-specific interactions with DNA and modulating transcriptional activity. While the precise physiological and pathological roles of ZNF324B are not fully elucidated, proteins in this family are known to regulate processes such as cell proliferation, differentiation, apoptosis, and responses to external signals. ZNF324B expression has been observed in various cancer types, suggesting it could play a role in oncogenic pathways or cancer biology, though there is no evidence of it being a direct therapeutic target or a current biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 324B (ZNF324B).